[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Pandemic optimism, excess deaths pessimism", "description": "UK, Zoe symptom study\n\nhttps://health-study.joinzoe.com/data\n\nDaily new cases = 106,548\n\nCurrent symptomatic prevalence = 1,488,559\n\nUK official data\n\nhttps://coronavirus.data.gov.uk\n\nPatients admitted, 4,124 down 14% (past 7 days)\n\nWith covid or for covid?\n\nDeaths, 419, down 38% (past 7 days)\n\nONS latest\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights\n\nW/E 23rd August, prevalence\n\n1.64% in England (1 in 60 people)\n\n1.56% in Wales (1 in 65 people) \n\n1.95% in Northern Ireland (1 in 50 people) \n\n1.82% in Scotland (1 in 55 people)\n\nReinfections within the omicron wave\n\n14.6%\n\nAlpha, 1.8%\n\nDelta, 1%\n\nRisk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants\n\nhttps://www.nejm.org/doi/full/10.1056/NEJMc2209479?query=TOC&cid=NEJM%20eToc,%20September%201,%202022%20DM1402792_NEJM_Non_Subscriber&bid=1141953912\n\nhttps://www.nejm.org/doi/suppl/10.1056/NEJMc2209479/suppl_file/nejmc2209479_appendix.pdf\n\nWuhan-Hu-1  55.7%\n\nAlpha   58.8%\n\nDelta   64.5%\n\nBA.1 / BA.2  76.8% \n\n(UK, 84.4%)\n\nLong covid\n\n2.0 million people in private households in the UK (3.1%)\n\nOf those\n\n83% symptoms at least 12 weeks\n\n45% at least one year\n\n22% at least two years\n\nSymptoms\n\nFatigue, 62%\n\nShortness of breath, 37%\n\nDifficulty concentrating, 33%\n\nMuscle ache, 31%\n\nSymptoms adversely affected the day-to-day activities\n\n1.5 million people, (73% of those with SRLC)\n\nChina, millions in Covid lockdown\n\nhttps://www.theguardian.com/world/2022/aug/31/china-places-millions-into-covid-lockdown-again-as-economy-continues-to-struggle\n\nChina, cases, + 1,717 cases, majority asymptomatic\n\nSporadic cases around China\n\nSouthern cities of Shenzhen and Guangzhou\n\nNorthern port city of Dalian\n\nWestern metropolis of Chengdu to Shijiazhuang\n\nCentral Hebei province\n\nVarying levels of restrictions, closure of venues and restaurants\n\nDelayed school reopening\n\nForeign visitors, more than a week of quarantine hotels, sanitary conditions often poor\n\nMasking and regular testing, close contacts forcibly transported to field hospitals\n\nWorld Health Organization, China\u2019s policy unsustainable\n\nAnbound Research Center\n\nPresident Xi Jinping\u2019s government, \n\nPreventing the risk of economic stall should be the priority task\n\nModerna sues Pfizer and BioNTech \n\nhttps://www.washingtonpost.com/business/2022/08/26/moderna-pfizer-covid-lawsuit/?utm_campaign=wp_to_your_health&utm_medium=email&utm_source=newsletter&wpisrc=nl_tyh\n\nhttps://www.documentcloud.org/documents/22266043-moderna-complaint?responsive=1&title=1\n\nMODERNA SUES PFIZER AND BIONTECH FOR INFRINGING PATENTS CENTRAL TO MODERNA'S INNOVATIVE MRNA TECHNOLOGY PLATFORM\nAUGUST, 26, 2022\n\nhttps://investors.modernatx.com/news/news-details/2022/Moderna-Sues-Pfizer-and-BioNTech-for-Infringing-Patents-Central-to-Modernas-Innovative-mRNA-Technology-Platform/default.aspx\n\nModerna Chief Legal Officer Shannon Thyme Klinger\n\nWe believe that Pfizer and BioNTech unlawfully copied Moderna\u2019s inventions, and they have continued to use them without permission\n\nPfizer\n\nWe are surprised by the litigation given the Pfizer/BioNTech COVID-19 vaccine was based on BioNTech\u2019s proprietary mRNA technology and developed by both BioNTech and Pfizer", "link": "https://www.youtube.com/watch?v=yPOEU1qCW_w", "date_published": "2022-09-03 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]